logo
logo

Latest Financial Updates

Read latest financial news update from our blog

IT Firms Focusing More On Lateral Hiring Over Freshers: Indeed India's Sashi Kumar
IT Firms Focusing More On Lateral Hiring Over Freshers: Indeed India's Sashi Kumar

India’s white-collar job market is seeing more hiring at the lateral levels than of the fr...

Admin | Finance | 7 weeks ago

read more
Results similar to 'will-jinxin-fertility-01951-hk-preempt-the-market-upon-policy-certainty--performance-elasticity'
Results similar to 'will-jinxin-fertility-01951-hk-preempt-the-market-upon-policy-certainty--performance-elasticity'

Results similar to 'will-jinxin-fertility-01951-hk-preempt-the-market-upon-policy-certaint...

Admin | Finance | 7 weeks ago

read more
Slow And Steady With Under Armour Stock (NYSE:UA)
Slow And Steady With Under Armour Stock (NYSE:UA)

JHVEPhoto Summary Under Armour (NYSE:UA, NYSE:UAA) has experienced huge litigation expen...

Admin | Finance | 7 weeks ago

read more
ASX Market Update: CBA breaks record as banks lead Index higher | September 6, 2024
ASX Market Update: CBA breaks record as banks lead Index higher | September 6, 2024

Join our daily newsletter At The Bell to receive exclusive market insights The ASX200 has...

Admin | Finance | 7 weeks ago

read more
ETMarkets Smart Talk: India’s economy to grow between 6.5% and 7% over next five years, says UBS Economist Tanvee Gupta Jain
ETMarkets Smart Talk: India’s economy to grow between 6.5% and 7% over next five years, says UBS Economist Tanvee Gupta Jain

(You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channe...

Admin | Finance | 7 weeks ago

read more
Editas Medicine, Inc. (EDIT) Presents at Wells Fargo 2024 Healthcare Conference (Transcript)
Editas Medicine, Inc. (EDIT) Presents at Wells Fargo 2024 Healthcare Conference (Transcript)

Editas Medicine, Inc. (NASDAQ:EDIT) Wells Fargo 2024 Healthcare Conference September 5, 20...

Admin | Finance | 7 weeks ago

read more
Verastem’s Path To FDA Approval: High-Risk, High-Reward Oncology Opportunity (NASDAQ:VSTM)
Verastem’s Path To FDA Approval: High-Risk, High-Reward Oncology Opportunity (NASDAQ:VSTM)

KatarzynaBialasiewicz/iStock via Getty Images Verastem, Inc. (NASDAQ:VSTM) is a clinical-...

Admin | Finance | 7 weeks ago

read more
Naturewings Holidays IPO Allotment; Step-By-Step Guide To Check Application Status
Naturewings Holidays IPO Allotment; Step-By-Step Guide To Check Application Status

The initial public offering of Naturewings Holidays Limited received a fabulous response f...

Admin | Finance | 7 weeks ago

read more

Join Our Newsletter

join our newsletter to receive update from us